Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic Rhinosinusitis with Nasal Polyps and Asthma
Tanya M. Laidlaw, Joaquim Mullol, Katharine M. Woessner, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 9, Iss. 3, pp. 1133-1141
Open Access | Times Cited: 261

Showing 1-25 of 261 citing articles:

Eosinophilic and Noneosinophilic Asthma
Liam G. Heaney, Luis Pérez de Llano, Mona Al‐Ahmad, et al.
CHEST Journal (2021) Vol. 160, Iss. 3, pp. 814-830
Open Access | Times Cited: 181
Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era
Joaquim Mullol, Antoine Azar, Kathleen M. Buchheit, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1434-1453.e9
Open Access | Times Cited: 91
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis
Jean Bousquet, Erik Melén, Tari Haahtela, et al.
Allergy (2023) Vol. 78, Iss. 5, pp. 1169-1203
Open Access | Times Cited: 55
The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps
Claus Bachert, Alexandra Hicks, Simon Gane, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach
Oliver Pfaar, Anju T. Peters, Camille Taillé, et al.
Clinical and Translational Allergy (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
Brian J. Lipworth, Joseph K. Han, Martin Desrosiers, et al.
New England Journal of Medicine (2025)
Closed Access | Times Cited: 2
Shared genetic investigation of asthma and blood eosinophils in relation to chronic rhinosinusitis
Xian Li, Jingyun Li, Shibei Xue, et al.
Allergy Asthma and Clinical Immunology (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Phenotype overlap in the natural history of asthma
Fabio Luigi Massimo Ricciardolo, Giuseppe Guida, Francesca Bertolini, et al.
European Respiratory Review (2023) Vol. 32, Iss. 168, pp. 220201-220201
Open Access | Times Cited: 35
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
Ilja Střı́ž, Korneliusz Golebski, Zuzana Střížová, et al.
Clinical Science (2023) Vol. 137, Iss. 9, pp. 727-753
Open Access | Times Cited: 33
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3371-3371
Open Access | Times Cited: 27
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
Tanya M. Laidlaw, Andrew Menzies‐Gow, Scott Caveney, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 915-932
Open Access | Times Cited: 27
Biologic treatment for severe chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis
Harsha H. Kariyawasam, Deepak P. Chandrasekharan, T Jacques, et al.
Rhinology Journal (2023) Vol. 61, Iss. 2, pp. 98-107
Open Access | Times Cited: 26
Exhaled Nitric Oxide as Biomarker of Type 2 Diseases
Mauro Maniscalco, Salvatore Fuschillo, Ilaria Mormile, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2518-2518
Open Access | Times Cited: 24
Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study
Alicia Padilla, Isabel Carmona, Pilar Ausín, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 22
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 23, Iss. 3, pp. 3696-3696
Open Access | Times Cited: 15
Treatable Traits in Asthma: The Importance of Extrapulmonary Traits—GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
Vanessa M. McDonald, Yuto Hamada, Àlvar Agustí, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 4, pp. 824-837
Closed Access | Times Cited: 13
Targeting Asthma Remission as the Next Therapeutic Step Toward Improving Disease Control
William W. Busse, Geoffrey Chupp, Thomas Corbridge, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 4, pp. 894-903
Open Access | Times Cited: 10
Long-Term Perspectives on Chronic Rhinosinusitis with Nasal Polyps: Evaluating Recurrence Rates after Functional Endoscopic Sinus Surgery in the Biologics Era—A 5-Year Follow-Up Study
Carlo Cavaliere, Simonetta Masieri, Elona Begvarfaj, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 297-297
Open Access | Times Cited: 10
Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia
F Fujieda, Chenwei Wang, Mamoru Yoshikawa, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 10
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
Laura Pini, Diego Bagnasco, Bianca Beghè, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 3013-3013
Open Access | Times Cited: 9
The use of biologics in patients suffering from chronic rhinosinusitis with nasal polyps – a 4-year real life observation
H. Frankenberger, Robert Wiebringhaus, Benedikt Paul, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 11, pp. 5773-5782
Open Access | Times Cited: 8
Long-Term Effectiveness of Dupilumab in Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Multicenter Retrospective Study
Paolo Russo, Edoardo Bassano, Marcella Menichetti, et al.
American Journal of Rhinology and Allergy (2025)
Closed Access | Times Cited: 1
Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study
Seung Won Lee, So Young Kim, Sung Yong Moon, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 6, pp. 2262-2271.e2
Open Access | Times Cited: 54
Highlights in the advances of chronic rhinosinusitis
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2021) Vol. 76, Iss. 11, pp. 3349-3358
Closed Access | Times Cited: 44
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy
Claus Bachert, Amber Luong, Philippe Gevaert, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2630-2641
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top